Company Profile
Nova Eye Medical designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma globally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease.
The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma. Its portfolio also includes iTrack Advance, and Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma. Incorporated in 1970 and headquartered in Kent Town, Australia, Nova Eye Medical was formerly known as Ellex Medical Lasers Limited before rebranding in July 2020.